BE1002239A5 - Solution pharmaceutique. - Google Patents

Solution pharmaceutique. Download PDF

Info

Publication number
BE1002239A5
BE1002239A5 BE8901159A BE8901159A BE1002239A5 BE 1002239 A5 BE1002239 A5 BE 1002239A5 BE 8901159 A BE8901159 A BE 8901159A BE 8901159 A BE8901159 A BE 8901159A BE 1002239 A5 BE1002239 A5 BE 1002239A5
Authority
BE
Belgium
Prior art keywords
solution
pharmaceutical solution
pharmaceutically acceptable
acceptable salt
active ingredient
Prior art date
Application number
BE8901159A
Other languages
English (en)
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Application granted granted Critical
Publication of BE1002239A5 publication Critical patent/BE1002239A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Une solution pharmaceutique contient, comme constituant actif A, de l'acide cromoglycique, ou un sel pharmaceutiquement acceptable de celui-ci, et, comme constituant actif B, du salbutamol, ou un sel pharmaceutiquement acceptable de celui-ci. La solution a un pH supérieur à 3,8 et inférieur à 4,8. Le constituant actif A est, de préférence, le cromoglycate de sodium et le constituant B, le sulfate de salbutamol. La solution est utile pour traiter des affections obstructives réversibles des voies respiratoires.
BE8901159A 1988-11-04 1989-10-31 Solution pharmaceutique. BE1002239A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888825892A GB8825892D0 (en) 1988-11-04 1988-11-04 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
BE1002239A5 true BE1002239A5 (fr) 1990-10-30

Family

ID=10646341

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8901159A BE1002239A5 (fr) 1988-11-04 1989-10-31 Solution pharmaceutique.

Country Status (19)

Country Link
EP (1) EP0370632B1 (fr)
JP (1) JPH02196716A (fr)
AU (1) AU620932B2 (fr)
BE (1) BE1002239A5 (fr)
CA (1) CA2002190A1 (fr)
CH (1) CH680191A5 (fr)
DE (1) DE68902300T2 (fr)
DK (1) DK548689A (fr)
ES (1) ES2023727A6 (fr)
FR (1) FR2638640B1 (fr)
GB (2) GB8825892D0 (fr)
GR (1) GR1000308B (fr)
IE (1) IE63433B1 (fr)
IL (1) IL92173A (fr)
IT (1) IT1239282B (fr)
LU (1) LU87615A1 (fr)
NZ (1) NZ231245A (fr)
PT (1) PT92188B (fr)
ZA (1) ZA898323B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4132176C2 (de) * 1991-09-27 1997-03-13 Ig Spruehtechnik Gmbh Dosieraerosole mit Isobutan als Treibmittel
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
GB9317752D0 (en) * 1993-08-26 1993-10-13 Fisons Plc New pharmaceutical use
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US20030215396A1 (en) 1999-09-15 2003-11-20 Boehringer Ingelheim Pharma Kg Method for the production of propellant gas-free aerosols from aqueous medicament preparations
JP2002017857A (ja) * 2000-06-26 2002-01-22 Ruian Pharmaceutic Co Ltd 投薬制御方法
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
EP1441709A1 (fr) * 2001-10-26 2004-08-04 Dey L.P. Solution d'inhalation a base d'albuterol, et systeme, kit et methode permettant de soulager les symptomes de l'asthme pediatrique
AU2006202584B2 (en) * 2001-10-26 2009-11-26 Mylan Specialty L.P. An albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US6702997B2 (en) * 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0406069D0 (en) * 2004-03-17 2004-04-21 Thompson James Process

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662601B2 (ja) * 1985-08-16 1994-08-17 京都薬品工業株式会社 クロモグリク酸誘導体および抗アレルギ−剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 108, no. 12, 21 mars 1988, page 440, résumé no. 101235j, Columbus, Ohio, US; M. IACONO et al.: "An investigation of the compatibility of ipratropium and sodium cromoglycate nebulizer solutions", & AUST. J. HOSP. PHARM. 1987, 17(3), 158-61 *

Also Published As

Publication number Publication date
IE893550L (en) 1990-05-04
DK548689D0 (da) 1989-11-03
GB8924052D0 (en) 1989-12-13
LU87615A1 (fr) 1991-05-07
IT8922216A0 (it) 1989-10-31
NZ231245A (en) 1990-12-21
DE68902300D1 (de) 1992-09-03
PT92188A (pt) 1990-05-31
EP0370632B1 (fr) 1992-07-29
CH680191A5 (fr) 1992-07-15
EP0370632A1 (fr) 1990-05-30
PT92188B (pt) 1996-01-31
JPH02196716A (ja) 1990-08-03
FR2638640B1 (fr) 1993-11-26
AU4396489A (en) 1990-05-10
DE68902300T2 (de) 1993-02-11
IL92173A (en) 1993-05-13
ES2023727A6 (es) 1992-02-01
CA2002190A1 (fr) 1990-05-04
IE63433B1 (en) 1995-04-19
GB2224932B (en) 1992-01-02
IT1239282B (it) 1993-10-19
IL92173A0 (en) 1990-07-12
GB2224932A (en) 1990-05-23
FR2638640A1 (fr) 1990-05-11
IT8922216A1 (it) 1991-05-01
GB8825892D0 (en) 1988-12-07
GR1000308B (el) 1992-05-12
DK548689A (da) 1990-05-05
GR890100726A (en) 1990-12-31
AU620932B2 (en) 1992-02-27
ZA898323B (en) 1990-07-25

Similar Documents

Publication Publication Date Title
BE1002239A5 (fr) Solution pharmaceutique.
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
RO91075A (fr) Procede pour la preparation des n-heterocyclyle-bicyclique-4-piperidinamine
NO174202C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt azainden-derivater
ATE255410T1 (de) Arzneimittel, das clodronat als wirkstoff und mit siliciumdioxid behandelte mikrokristalline cellulose als füllstoff enthält
SG120493G (en) N-tert-Butyl-decahydro-2(3-amino-2-hydroxy-4-phenyl-butyl) isoquinoline-3-carboxamide and asparaginyl derivatives thereof
PT99597B (pt) Processo para a preparacao de derivados do acido hidroxamico que inibem a lipoxigenase
HUT42948A (en) Process for production of medical compositions suitable for transdermal treatment containing as active substance derivatives of 2-amin-3-aroil-benzol-acetic acid
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
ES8706668A1 (es) Un procedimiento para la preparacion de derivados de piperidina.
FR2440376A1 (fr) Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
TNSN03106A1 (fr) Procede pour la production d'une composition pharmaceutique a faible dose ayant une distribution et activite medicamenteuse uniforme
BR9713921A (pt) Composto, composição farmacêutica, processo para tógico capaz de ser modulado através da inibição do fator xa
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
NO932947L (no) Antimikrobielt middel
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
ES2052000T3 (es) Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina.
NZ334571A (en) Pharmaceutical composition comprising 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy-acetic acid for treating diseases induced by respiratory syncytial virus
HUT41740A (en) Process for production of new medically effective imidasolidins and medical preparatives containing thereof
EP0383481A3 (fr) Compositions anesthésiques buccales
NO170014C (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse (3s(z))-2-(((1-(2-amino-4-tiazolyl)-2-((2,2-dimetyl-4-okso-1-(sulfooksy)-3-azetidinyl)amino)-2-oksoetyliden)amino)oksy)-eddiksyre
ATE24716T1 (de) Lenkotrien-antagonisten.
EP0250508A1 (fr) Medicament pour le traitement des maladies du foie
FI853868L (fi) Pyridinderivat, foerfarande foer framstaellning av dessa och farmaceutiska foereningar innehaollande dessa.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FISONS PLC.

Effective date: 19971031